Japan’s MHLW Off-Label Drugs Committee Validates Levonorgestrel For Menorrhagia
This article was originally published in PharmAsia News
Executive Summary
MHLW Japan’s Evaluation Committee on unapproved or off-label drugs with high medical needs, released its report on Jan. 16, which validated levonorgestrel-releasing intrauterine system, sold as Mirena by Bayer, for menorrhagia.